Schechter Investment Advisors, LLC Amgen Inc Transaction History

Schechter Investment Advisors, LLC

$997 Million
Q3 2024

A detailed history of Schechter Investment Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 7,219 shares of AMGN stock, worth $1.9 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

7,219

Previous 7,232 0.18%

Holding current value

$1.9 Million

Previous $2.26 Million 2.97%

% of portfolio

0.23%

Previous 0.23%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $4,021 - $4,385	-13 Reduced 0.18%	7,219 $2.33 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $103,786 - $126,127	395 Added 5.78%	7,232 $2.26 Million
Q1 2024 May 06, 2024	SELL	$268.87 - $324.56 $100,288 - $121,060	-373 Reduced 5.17%	6,837 $1.94 Million
Q4 2023 Jan 17, 2024	SELL	$255.7 - $288.46 $48,583 - $54,807	-190 Reduced 2.57%	7,210 $2.08 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $347,216 - $431,078	1,588 Added 27.32%	7,400 $1.99 Million
Q2 2023 Jul 26, 2023	SELL	$214.27 - $253.37 $206,770 - $244,502	-965 Reduced 14.24%	5,812 $1.29 Million
Q1 2023 Apr 28, 2023	BUY	$225.79 - $275.2 $422,001 - $514,348	1,869 Added 38.08%	6,777 $1.64 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $57,028 - $72,461	249 Added 5.34%	4,908 $1.29 Million
Q3 2022 Nov 04, 2022	SELL	$224.46 - $253.15 $62,848 - $70,882	-280 Reduced 5.67%	4,659 $1.05 Million
Q2 2022 Nov 03, 2022	BUY	$230.71 - $256.74 $1.14 Million - $1.27 Million	4,939 New	4,939 $1.2 Million
Q1 2022 Nov 18, 2022	SELL	$219.27 - $242.57 $42,099 - $46,573	-192 Reduced 4.12%	4,467 $1.08 Million
Q4 2021 Dec 27, 2022	SELL	$198.88 - $227.6 $136,232 - $155,906	-685 Reduced 14.7%	3,974 $894,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.

Account

Schechter Investment Advisors, LLC Amgen Inc Transaction History